為先導藥物最適化之以結構為基礎的片段遷越及合成可行性之改良 刊登日期:2014/05/21
  ‧ 專利名稱 為先導藥物最適化之以結構為基礎的片段遷越及合成可行性之改良
  ‧ 專利證書號 I611053
  ‧ 專利權人 國立臺灣大學
  ‧ 專利國家
    (申請日)
中華民國 (2013/02/27)
美國 (2013/02/27)
  ‧ 發明人 曾宇鳳, 林芳宇,
 
技術摘要:
The invention develops a computer-aided drug design method and system to optimize a lead through structure-based drug design with synthetic accessibility. In this invention, two systems of the structure-based lead optimization are developed and implemented: 1) LeadOp ("short for lead optimization")--an algorithm that performs lead optimization through structure-based fragment hopping method; and 2) LeadOp+R (short for "lead optimization with synthetic accessibility based on chemical reaction route")--an algorithm that performs lead optimization with synthetic accessibility. LeadOp algorithm provides users to optimize a lead compound with various combinations of fragments with stronger binding based on group efficiency, generating lead with stronger potency. Furthermore, LeadOp+R provides an advantage in the selection of the new fragment to be assembled, which was identified based on the group efficiency calculated in the active site and reaction rule.



聯繫方式
聯絡人: 研發處產學合作總中心 電話: (02)3366-9949
地 址: 10617臺北市大安區羅斯福路四段1號 禮賢樓六樓608室